Get the Stockscreener App
0.00
100.00%
-10.25
After Hours:
10.25
10.25
+
Gracell Biotechnologies Inc ADR Stock (GRCL) Forecast
The Gracell Biotechnologies Inc ADR (GRCL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.3553, representing a + increase from the current price of $0.00. The highest analyst price target is $7.4989, and the lowest is $1.2116.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GRCL Price Target
Average 5.5753
(+ Upside)
Is Gracell Biotechnologies Inc ADR (GRCL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 5.68 | Buy |
| STOCH(9,6) | 28.57 | Neutral |
| STOCHRSI(14) | 19.05 | Buy |
| MACD(12,26) | -0.561 | Sell |
| ADX(14) | 59.22 | Sell |
| William %R | -100.00 | Buy |
| CCI(14) | -466.67 | Sell |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.2255
Sell
|
8.3677
Sell
|
| MA20 |
9.7028
Sell
|
9.144
Sell
|
| MA50 |
9.0273
Sell
|
8.6619
Sell
|
| MA100 |
6.4348
Sell
|
7.2522
Sell
|
| MA200 |
5.0014
Sell
|
5.5979
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, GRCL could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 13 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on GRCL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 5.68 indicates that GRCL is oversold. This indicates that GRCL price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 28.57 indicates that GRCL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 19.05 indicates that GRCL is oversold. This suggests that GRCL price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 59.22 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -466.67 indicates that GRCL is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term GRCL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Gracell Biotechnologies Inc ADR financial reports and earnings history, Gracell Biotechnologies Inc ADR (GRCL) stock could reach $16.09 by 2030, $66.57 by 2040 and $134.15 by 2050. See the projected annual prices until 2050 of the Gracell Biotechnologies Inc ADR stock below:
- Gracell Biotechnologies Inc ADR (GRCL) is expected to reach an average price of $64.98 in 2035, with a high prediction of $72.69 and a low estimate of $65.79. This indicates an $ rise from the last recorded price of $0.00.
- Gracell Biotechnologies Inc ADR (GRCL) stock is projected to chart a bullish course in 2040, with an average price target of $64.82, representing an $ surge from its current level. The forecast ranges from a conservative $64.95 to a sky-high $66.57.
- Our analysts predict Gracell Biotechnologies Inc ADR (GRCL) to jump by 2045, soaring from $19.63 to an average price of $19.37, potentially reaching $21.29. While $19.63 is the low estimate, the potential upside is significant.
- Gracell Biotechnologies Inc ADR (GRCL) stock is expected to climb by 2050, reaching an average of $132.34, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $134.15 and $132.40, respectively, highlighting the market's uncertainty.
Gracell Biotechnologies Inc ADR Stock (GRCL) Year by Year Forecast
Gracell Biotechnologies Inc ADR Stock (GRCL) Price Forecast for 2024
Our forecast for GRCL stock price in 2024 now indicates an average price target of $5.2175 with a high forecast of $10.44 and a low forecast of $0.00. The average prediction reflects an increase of + from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $2.0719 | $1.2116 | $7.4989 | + |
| July, 2024 | $7.173 | $0.8824 | $4.894 | + |
| August, 2024 | $9.7443 | $9.2932 | $8.7643 | + |
| September, 2024 | $6.3454 | $8.2854 | $9.7749 | + |
| October, 2024 | $7.7568 | $7.7062 | $7.2668 | + |
| November, 2024 | $8.3178 | $9.012 | $8.2976 | + |
| December, 2024 | $9.4989 | $8.8586 | $7.6581 | + |
Gracell Biotechnologies Inc ADR Stock (GRCL) Price Forecast for 2025
Gracell Biotechnologies Inc ADR Stock (GRCL) is expected to reach an average price of $8.8997 in 2025, with a high prediction of $12.65 and a low estimate of $5.1511. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.3203 | $6.7503 | $8.8495 | + |
| February, 2025 | $5.0014 | $5.1511 | $4.8965 | + |
| March, 2025 | $6.4024 | $5.5616 | $7.0122 | + |
| April, 2025 | $9.7735 | $7.0777 | $9.7735 | + |
| May, 2025 | $10.82 | $10.84 | $10.27 | + |
| June, 2025 | $12.96 | $12.10 | $11.88 | + |
| July, 2025 | $12.37 | $12.50 | $12.51 | + |
| August, 2025 | $13.01 | $12.41 | $12.65 | + |
| September, 2025 | $12.36 | $12.57 | $12.39 | + |
| October, 2025 | $10.68 | $11.66 | $12.28 | + |
| November, 2025 | $10.71 | $10.46 | $10.25 | + |
| December, 2025 | $7.473 | $8.103 | $9.863 | + |
Gracell Biotechnologies Inc ADR Stock (GRCL) Price Forecast for 2026
The predicted value for Gracell Biotechnologies Inc ADR (GRCL) in 2026 is set at an average of $6.3654. Estimates vary from a peak of $8.9362 to a trough of $3.7946, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.7943 | $7.9632 | $8.4343 | + |
| February, 2026 | $9.0154 | $8.7649 | $8.4454 | + |
| March, 2026 | $9.1365 | $9.1759 | $8.9362 | + |
| April, 2026 | $7.5978 | $7.9178 | $8.4968 | + |
| May, 2026 | $6.3689 | $7.0047 | $7.1681 | + |
| June, 2026 | $6.30 | $6.45 | $6.2297 | + |
| July, 2026 | $6.8014 | $6.9014 | $6.7808 | + |
| August, 2026 | $6.2824 | $6.4424 | $6.4616 | + |
| September, 2026 | $5.9135 | $5.9635 | $5.7685 | + |
| October, 2026 | $5.2849 | $5.3321 | $5.6638 | + |
| November, 2026 | $4.9559 | $5.0059 | $5.1051 | + |
| December, 2026 | $3.2973 | $3.7946 | $4.7912 | + |
Gracell Biotechnologies Inc ADR Stock (GRCL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Gracell Biotechnologies Inc ADR (GRCL) is $12.65, with a high forecast of $25.21 and a low forecast of $0.0791. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6684 | $1.5014 | $3.0676 | + |
| February, 2027 | $0.1595 | $0.6795 | $1.0189 | + |
| March, 2027 | $1.1205 | $0.7997 | $0.6205 | + |
| April, 2027 | $0.3719 | $0.5919 | $0.5314 | + |
| May, 2027 | $0.493 | $0.543 | $0.2624 | + |
| June, 2027 | $0.3659 | $0.0791 | $0.4659 | + |
| July, 2027 | $2.8446 | $0.3557 | $3.2346 | + |
| August, 2027 | $3.9735 | $1.7244 | $4.1135 | + |
| September, 2027 | $8.9522 | $3.8032 | $9.0022 | + |
| October, 2027 | $9.8311 | $9.0569 | $9.9161 | + |
| November, 2027 | $24.00 | $9.7008 | $21.80 | + |
| December, 2027 | $20.54 | $18.83 | $25.21 | + |
Gracell Biotechnologies Inc ADR Stock (GRCL) Price Forecast for 2028
In 2028, Gracell Biotechnologies Inc ADR (GRCL) is projected to reach an average price of $27.58, with a high projection of $31.44 and a low estimate of $23.71. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $22.16 | $23.71 | $21.22 | + |
| February, 2028 | $31.13 | $28.12 | $29.14 | + |
| March, 2028 | $32.28 | $31.78 | $31.44 | + |
| April, 2028 | $27.92 | $29.02 | $27.21 | + |
| May, 2028 | $29.12 | $28.64 | $28.25 | + |
| June, 2028 | $28.36 | $29.38 | $28.67 | + |
| July, 2028 | $28.49 | $28.71 | $28.31 | + |
| August, 2028 | $23.65 | $24.62 | $27.14 | + |
| September, 2028 | $26.02 | $23.83 | $23.33 | + |
| October, 2028 | $26.72 | $24.98 | $25.17 | + |
| November, 2028 | $27.63 | $28.25 | $27.29 | + |
| December, 2028 | $28.62 | $27.83 | $27.86 | + |
Gracell Biotechnologies Inc ADR Stock (GRCL) Price Forecast for 2029
The 2029 price forecast for Gracell Biotechnologies Inc ADR Stock (GRCL) is $22.59 on average, with a high prediction of $28.72 and a low estimate of $16.46. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $29.12 | $28.92 | $28.72 | + |
| February, 2029 | $27.95 | $27.98 | $27.85 | + |
| March, 2029 | $27.51 | $27.61 | $27.83 | + |
| April, 2029 | $26.77 | $26.94 | $27.18 | + |
| May, 2029 | $24.35 | $24.64 | $26.16 | + |
| June, 2029 | $22.23 | $23.68 | $23.74 | + |
| July, 2029 | $21.12 | $20.81 | $20.51 | + |
| August, 2029 | $20.75 | $20.83 | $20.76 | + |
| September, 2029 | $20.69 | $20.72 | $20.52 | + |
| October, 2029 | $18.83 | $19.78 | $20.35 | + |
| November, 2029 | $17.57 | $17.80 | $18.22 | + |
| December, 2029 | $16.35 | $16.46 | $16.44 | + |
Gracell Biotechnologies Inc ADR Stock (GRCL) Price Forecast for 2030
Gracell Biotechnologies Inc ADR Stock (GRCL) is expected to reach an average price of $9.9841 in 2030, with a high forecast of $16.09 and a low forecast of $3.877. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $16.16 | $16.05 | $16.09 | + |
| February, 2030 | $15.18 | $15.50 | $15.59 | + |
| March, 2030 | $14.18 | $14.23 | $14.88 | + |
| April, 2030 | $13.29 | $13.36 | $13.81 | + |
| May, 2030 | $12.13 | $12.16 | $12.91 | + |
| June, 2030 | $10.90 | $11.22 | $11.76 | + |
| July, 2030 | $9.1951 | $9.2351 | $10.52 | + |
| August, 2030 | $6.8278 | $7.0798 | $8.5858 | + |
| September, 2030 | $5.60 | $5.7295 | $5.5284 | + |
| October, 2030 | $4.7327 | $5.2727 | $5.2905 | + |
| November, 2030 | $4.0349 | $4.2449 | $4.2332 | + |
| December, 2030 | $3.797 | $3.877 | $3.6758 | + |
0.58%
1.18%
Cap:
|
Volume (24h):